Samsung Biologics makes $1.8 billion all-cash offer for Switzerland's PolyPeptide Group

Jul 19, 2026 - 23:25

0 0

Samsung Biologics makes $1.8 billion all-cash offer for Switzerland's PolyPeptide Group

South Korea's Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland's PolyPeptide Group.

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

Business Insider analyzed federal student loan data for all 50 states, finding 42.3 million borrowers owed more than $1.72 trillion as of June 30, with an estimated average balance of $40,768 nationwide.

Business Insider analyzed federal student loan data for...

Oct 2, 2026 0 0

Robotics startup FieldAI has raised $700 million at a $10 billion valuation, more than quadrupling its value in just over a year as investors back its general-purpose software for robots, drones and industrial machines.

Robotics startup FieldAI has raised $700 million at a $...

Oct 2, 2026 0 0

Burger King is selling about 200 U.S. company-operated restaurants to franchisees this year as part of a turnaround push that aims to leave most of its more than 6,000 U.S. locations in local hands.

Burger King is selling about 200 U.S. company-operated ...

Oct 2, 2026 0 0

U.S. nonfarm payrolls increased by 29,000 in September, below expectations, while the unemployment rate rose to 4.2%, according to the September 2026 jobs report.

U.S. nonfarm payrolls increased by 29,000 in September,...

Oct 2, 2026 0 0

South Korea is taking a cautious approach to the Alaska LNG project even as President Donald Trump says the two countries agreed to work on it as part of Seoul’s $200 billion U.S. investment package.

South Korea is taking a cautious approach to the Alaska...

Oct 2, 2026 0 0

A decades-old legal battle over hedge fund compensation is heading to a third trial in late October, with $165 million at stake as former traders Gentry Beach and Robert Vollero pursue claims against Paul Touradji.

A decades-old legal battle over hedge fund compensation...

Oct 2, 2026 0 0